MCA logo

PUBLIC PORTAL

invest selangor

MEDICALLY REVIEWED

HSA approves the first JAK inhibitor for moderate-to-severe atopic dermatitis: baricitinib (Olumiant)

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

Groundbreaking Ureter Repair Using Mouth Tissue at NUH

This meticulous surgery required the combined expertise of specialists in kidney surgery, transplantation, and functional urology. The team delicately sutured the patient’s buccal mucosa to the ureter, ensuring a blood supply through the omentum. The choice of the buccal mucosa was strategic, given its resilience and compatibility with urinary tract tissues.

Read More »